Pharmaceutical 3509 articles

Beasley Allen has one of the largest and most technologically advanced Mass Torts practices in the country. The Mass Torts division represents numerous people in claims against companies that manufacture and/or market defective pharmaceuticals and/or medical devices. The resources devoted to this division allow the firm to competently and conscientiously handle any group of cases, no matter how large, along with particular catastrophic injury cases.

Our firm was recently involved in one of the greatest victories in Mass Torts history, against drug manufacturer Merck regarding the drug Vioxx. After more than five years of hard-fought and difficult litigation, Merck agreed to pay $4.85 billion, the largest pharmaceutical settlement in U.S. history, to resolve certain Vioxx-related claims involving plaintiffs who suffered a heart attack, including sudden cardiac death, or a stroke.

Lawsuits against Pfizer expected to mount as news of Viagra-melanoma link emerges


A study linking the erectile dysfunction drug Viagra to an 84 percent risk of developing melanoma over a 10-year period has prompted many men to file lawsuits against the drug’s maker in hopes of getting compensation for their injuries. The study, published in June in JAMA Internal Medicine, took many laymen by surprise. How could a drug designed to put men in “the mood” cause them to develop the deadliest form of skin cancer? But scientists already had a hunch that the drug could make men more susceptible to the disease. The reason? Viagra and other erectile dysfunction drugs are ... Read More

Pfizer pays $400 million to settle claims it misled investors with illegal marketing scheme

pfizer hq

Pfizer Inc. has agreed to pay $400 million to settle a class action lawsuit waged by shareholders claiming the drug company misled investors about an alleged off-label marketing scheme involving four of its drugs. The case grew out of a government investigation into Pfizer’s illegal marketing practices and kickback payments to physicians. In 2009, the drug company pled guilty to off-label marketing of its anti-inflammatory drug Bextra, and paid $2.3 billion to settle with the government. Bextra was withdrawn from the market in 2005 due to serious side effects including cardiovascular risks and deadly skin reactions. The shareholder lawsuit claims ... Read More

Antidepressants, antihistamines linked to increased risk of dementia

Senior African American couple

Commonly used prescription and over-the-counter medicines including antidepressants and antihistamines, have been strongly linked to an increased risk of dementia, according to a study published in the journal JAMA Internal Medicine. All the drugs studied have what researchers call an “anticholinergic” effect, meaning they work by blocking the neurotransmitter acetylcholine in the central and peripheral nervous system. Higher doses and prolonged use of the medications were linked to a higher risk in the elderly. The study did not specify brand names of medications involved in the research, but it does identify the types of drugs studied. They include tricyclic antidepressants; ... Read More

Scientists developing breakthrough therapies for pancreatic cancer

januvia - sitagliptin

Breakthrough therapies are currently in development designed to improve survival in patients with pancreatic cancer, one of the deadliest forms of the disease, the Food and Drug Administration (FDA) announced. Patients with pancreatic cancer often don’t experience symptoms of the disease until it has spread to other parts of the body, when it is more difficult to treat. The most common symptoms that bring patients to the doctor are jaundice, back pain and unexplained weight loss. Other symptoms include new onset diabetes or worsening diabetes, nausea, vomiting, bowel changes, tiredness, weakness, and changes in appetite. Surgery is the only hope ... Read More

Woman disabled by shoulder pain pump gets another day in court


An Oregon woman who claims she was permanently disabled by a pain pump used following shoulder surgery is being given another stab at suing the company that manufactured the alleged defective device. Christina McClellan underwent two surgeries to repair her shoulder joint, after which she was prescribed painkillers delivered through I-Flow’s Pain Buster pain pump, manufactured by Kimberly-Clark. After her second surgery in 2004, she was diagnosed with chondrolysis, or the loss of cartilage, in her shoulder joint. This caused the ball-and-socket portion of her shoulder to fuse together. She now has no motion in her shoulder joint and doctors say ... Read More

Plaintiffs attorneys say transvaginal mesh victims should not have to prove their injuries

transvaginal mesh

Johnson & Johnson’s request that plaintiffs in a multidistrict litigation (MDL) who allege the company’s transvaginal mesh was defective prove they were injured is ludicrous and nothing more than a delay tactic, plaintiffs attorneys said responding to a Jan. 13 motion by the consumer health care and pharmaceutical giant. Johnson & Johnson and its subsidiary Ethicon Inc., asked that the near-24,000 plaintiffs in the multidistrict litigation prove thy were injured by the company’s transvaginal mesh, and asked the court to require every plaintiff’s attorney to answer under oath certain questions on how plaintiffs were solicited. The companies claim that “unscrupulous” ... Read More

Janssen knew Risperdal could cause boys to grow breasts


Johnson & Johnson unit Janssen Pharmaceuticals knew for years that its antipsychotic drug Risperdal could cause the abnormal growth of breasts in boys and young men, yet the company failed to warn the mother of an Alabama boy or his doctors of these “distressing results,” the mother’s attorney told a Philadelphia jury. “We’re going to show you that Janssen knew all the time that he took the drug that the drug caused an increase in prolactin levels, and that it was associated with children and adolescents having this distressing result,” the attorney said. Austin Pledger, now 20, was prescribed Risperdal ... Read More

Plaintiffs identify Philadelphia woman as model case for Zimmer knee implant lawsuit

Zimmer knee

Plaintiffs in a multidistrict litigation involving alleged defects with Zimmer knee implants asked an Illinois federal judge to select the case of a Philadelphia woman to serve as the first bellwether trial, claiming that the woman’s age, gender and implant type best represent plaintiffs’ issues with the implants. Ramona Diano, 72, had Zimmer LPS Flex Gender femoral components implanted in both knees. Both implants failed. Plaintiffs say that Diano is in the most common age group and gender for the procedure, and her case has the least individual issues among the other cases previously identified as possible bellwethers. Dinao’s lawsuit ... Read More

Bellwether cases soon to be selected for Mentor Corp transvaginal mesh

transvaginal mesh

A Georgia federal judge identified six possible bellwether cases out of hundreds accusing Johnson & Johnson unit Mentor Corp of not informing patients or doctors of the risks associated with its ObTape sling transvaginal mesh device used to treat urinary incontinence in women. U.S. District Judge Clay D. Land ordered the parties to select two of the six lawsuits within three weeks. The cases will be tried in October and November 2015. The lawsuits allege Mentor marketed the defective devices, which caused serious injuries to women. Mentor discontinued the implants in 2006. Transvaginal mesh is used to treat pelvic organ ... Read More

FDA approves new drug to treat plaque psoriasis


Federal drug regulators have approved Novartis AG’s new drug Cosentyx designed to dramatically improve symptoms of moderate-to-severe plaque psoriasis. The approval gives the Swiss pharmaceutical company first market share against competitors Eli Lilly & Co. and Amgen Inc., both of which are seeking approval for similar treatments. Psoriasis is is a skin condition that causes patches of skin redness and irritation. The most common form of the autoimmune disorder is plaque psoriasis, which causes patients to develop thick, red skin with flaky, silver-white patches called scales. An estimated 7.5 million Americans have psoriasis. Cosentyx contains the active ingredient secukinumab, an ... Read More